Kissei Pharmaceutical Co., Ltd. (KSPHF)
USD 25.0
(0.0%)
USD 25.0
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 75.57 Billion | 508.01 Million | 537.1 Million | 624.83 Million | 585.84 Million | 653.22 Million |
| Cost of Revenue | 41.15 Billion | 284.46 Million | 298.69 Million | 345.3 Million | 271.64 Million | 249.75 Million |
| Gross Profit | 34.42 Billion | 223.55 Million | 238.4 Million | 279.52 Million | 314.2 Million | 403.46 Million |
| Operating Expenses | 30.4 Billion | 232.16 Million | 249.92 Million | 265.9 Million | 297 Million | 347.41 Million |
| Selling, General and Administrative Expenses | - | 152.82 Million | 163.66 Million | 177.43 Million | 195.75 Million | 203.97 Million |
| Research and Development Expenses | - | 78.21 Million | 85.13 Million | 87.11 Million | 99.73 Million | 141.94 Million |
| Other Expenses | 30.4 Billion | -1.12 Million | -1.12 Million | -1.34 Million | -1.5 Million | -1.49 Million |
| Cost and Expenses | 71.56 Billion | 516.62 Million | 548.62 Million | 611.2 Million | 568.64 Million | 597.17 Million |
| Operating Income | 4.01 Billion | -8.6 Million | -11.51 Million | 13.62 Million | 17.2 Million | 56.05 Million |
| Interest Expense | 18 Million | 150.54 Thousand | 188.94 Thousand | 208.14 Thousand | 213.05 Thousand | 207.79 Thousand |
| Income Tax Expense | 3.15 Billion | 22.92 Million | 28.54 Million | 18.98 Million | 16.12 Million | 14.32 Million |
| Earnings before Tax | 14.44 Billion | 102.96 Million | 135.6 Million | 67.65 Million | 42.88 Million | 64.33 Million |
| Net Income | 11.16 Billion | 79.25 Million | 106.15 Million | 47.82 Million | 26.09 Million | 49.51 Million |
| Earnings Per Share Basic | 246.58 | 1.72 | 2.30 | 1.02 | 0.56 | 1.06 |
| Earnings Per Share Diluted | 246.58 | 1.72 | 2.30 | 1.02 | 0.56 | 1.06 |
| Weighted Average Shares Outstanding | 45.25 Million | 46.11 Million | 46.11 Million | 46.66 Million | 46.71 Million | 46.71 Million |
| Weighted Average Shares Outstanding (Diluted) | 45.25 Million | 46.11 Million | 46.11 Million | 46.66 Million | 46.71 Million | 46.71 Million |
| Gross Margin | 0.46 | 0.44 | 0.44 | 0.45 | 0.54 | 0.62 |
| EBIT Margin | 0.25 | 0.04 | 0.04 | 0.07 | 0.07 | 0.12 |
| Profit Margin | 0.15 | 0.16 | 0.20 | 0.08 | 0.04 | 0.08 |
| EBITDA | 18.72 Billion | 22.32 Million | 19.12 Million | 42.11 Million | 40.93 Million | 9.75 Billion |
| Earnings Before Tax Margin | 0.05 | -0.02 | -0.02 | 0.02 | 0.03 | 0.09 |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Revenue | 75.57 Billion | 17.72 Billion | 147.98 Million | 118.21 Million | 133.8 Million | 508.01 Million |
| Cost of Revenue | 41.15 Billion | 8.94 Billion | 75.24 Million | 59.87 Million | 67.4 Million | 284.46 Million |
| Gross Profit | 34.42 Billion | 8.77 Billion | 72.74 Million | 58.34 Million | 66.39 Million | 223.55 Million |
| Operating Expenses | 30.4 Billion | 8.92 Billion | 57.51 Million | 55.77 Million | 55.07 Million | 232.16 Million |
| Selling, General and Administrative Expenses | - | 8.92 Billion | 41.48 Million | 40.39 Million | 39.82 Million | - |
| Research and Development Expenses | - | 2.71 Billion | 16.03 Million | 15.37 Million | 15.24 Million | - |
| Other Expenses | -143 Million | 17 Million | 2 Million | -1 Million | 17 Million | -1.12 Million |
| Cost and Expenses | 71.56 Billion | 17.86 Billion | 132.76 Million | 115.65 Million | 122.48 Million | 516.62 Million |
| Operating Income | 4.01 Billion | -148 Million | 15.22 Million | 2.56 Million | 11.32 Million | -8.6 Million |
| Interest Expense | 18 Million | 5 Million | 28.34 Thousand | 33.46 Thousand | 27.71 Thousand | 150.54 Thousand |
| Income Tax Expense | 3.15 Billion | 511 Million | 6.39 Million | 4.81 Million | 7.1 Million | 22.92 Million |
| Earnings before Tax | 14.44 Billion | 3.34 Billion | 25.49 Million | 21.09 Million | 30.12 Million | 102.96 Million |
| Net Income | 11.16 Billion | 2.82 Billion | 18.83 Million | 16.14 Million | 22.62 Million | 79.25 Million |
| Earnings Per Share Basic | - | 62.40 | 0.42 | 0.35 | 0.49 | - |
| Earnings Per Share Diluted | - | 62.40 | 0.42 | 0.35 | 0.49 | - |
| Weighted Average Shares Outstanding | 45.25 Million | 45.25 Million | 44.93 Million | 45.81 Million | 46.02 Million | 46.11 Million |
| Weighted Average Shares Outstanding (Diluted) | 45.25 Million | 45.25 Million | 44.93 Million | 45.81 Million | 46.02 Million | 46.11 Million |
| Gross Margin | 0.46 | 0.50 | 0.49 | 0.49 | 0.50 | 0.44 |
| EBIT Margin | - | 0.06 | 0.15 | 0.08 | 0.14 | - |
| Profit Margin | 0.15 | 0.16 | 0.13 | 0.14 | 0.17 | 0.16 |
| EBITDA | - | 990 Million | 22.78 Million | 9.44 Million | 18.39 Million | - |
| Earnings Before Tax Margin | 0.05 | -0.01 | 0.10 | 0.02 | 0.08 | -0.02 |
GARNET
TMR
W7L
CELL
4825
SCZC